One-hour post-load plasma glucose and IGF-1 in hypertensive patients

European Journal of Clinical Investigation

Volumn 42, Issue 12, 2012, Pages 1325-1331

  Perticone, Francesco ^a   Sciacqua, Angela ^a   Tassone, Eliezer J ^a   Miceli, Sofia ^a   Maio, Raffaele ^a   Addesi, Desirée ^a   Falbo, Tania ^a   Arturi, Franco ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Essential hypertension; Glucose tolerance; Insulin resistance; Insulin like growth factor 1

Indexed keywords

GLUCOSE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMMUNORADIOMETRIC ASSAY; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TIME FACTORS;

EID: 84869886482     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12005     Document Type: Article

References (36)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-44.
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
4. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 2002;287:2570-81.
5. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405.
6. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-50.
7. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005;54:1-7.
8. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'grady MJ, Welty TK et al. Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study. Am Heart J 2001;141:992-8.
9. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M et al. Plasma concentration of IGF-1 is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005;28:132-7.
10. Perticone F, Sciacqua A, Perticone M, Laino I, Miceli S, Care' I et al. Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J Clin Endocrinol Metab 2008;93:2806-10.
11. Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S et al. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol 1996;77:200-2.
12. Sesti G, Sciacqua A, Scozzafava A, Vatrano M, Angotti E, Ruberto C et al. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J Hypertens 2007;25:471-7.
13. Perticone F, Maio R, Sciacqua A, Perticone M, Laino I, Miceli S et al. Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients. J Hypertens 2009;27:613-7.
14. Colao A, Di Somma C, Cascella T, Pivonello R, Vitale G, Grasso LFS et al. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol 2008;159:389-97.
15. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006;22:423-36.
16. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-81.
17. Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008;31:1650-5.
18. Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, Andreozzi F et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 2009;207:245-9.
19. Succurro E, Arturi F, Lugarà M, Grembiale A, Fiorentino TV, Caruso V et al. One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol 2010;5:1922-7.
20. Sciacqua A, Miceli S, Carullo G, Greco L, Succurro E, Arturi F, et al. 1-h postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 2011;34:1-6.
21. Sciacqua A, Miceli S, Greco L, Arturi F, Naccarato P, Mazzaferro D et al. One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care 2011;34:2291-6.
22. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
23. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
24. Perticone F, Sciacqua A, Perticone M, Miceli S, Maio R, Tassone JE et al. Phenotypic characterization of normotolerant hypertensive patients. Int J Cardiol 2011. [Epub ahead of print].
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
26. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
27. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). Ann Intern Med 2009;150:604-12.
28. Bondanelli M, Ambrosio MR, Onofri A, Bergonzoni A, Lavezzi S, Zatelli MC et al. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J Clin Endocrinol Metab 2006;91:3928-34.
29. Colao A, Spiezia S, Di Somma C, Pivonello R, Marzullo P, Rota F et al. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age. J Endocrinol Investig 2005;28:440-8.
30. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002;359:1740-5.
31. Clemmons DR. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol 2006;6:620-5.
32. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
33. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-42.
34. Perticone F, Maio R, Andreozzi F, Iemma G, Perticone M, Zoccali C et al. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension. Diabetes 2008;57:167-71.
35. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004;53:693-700.
36. Lee CC, Adler AI, Sandhu MS, Sharp SJ, Forouhi NG, Erqou S et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 2009;52:1040-7.